Daiichi Life Insurance Co. Ltd. Purchases New Stake in Cigna Group $CI

Daiichi Life Insurance Co. Ltd. acquired a new position in shares of Cigna Group (NYSE:CI) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 8,333 shares of the health services provider’s stock, valued at approximately $2,297,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $25,000. Kemnay Advisory Services Inc. purchased a new position in Cigna Group in the fourth quarter valued at approximately $29,000. Prosperity Bancshares Inc purchased a new position in Cigna Group in the fourth quarter valued at approximately $29,000. Johnson Financial Group Inc. bought a new position in Cigna Group during the second quarter valued at $29,000. Finally, Cedar Mountain Advisors LLC grew its holdings in Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CI has been the topic of several research reports. Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their target price for the company from $350.00 to $320.00 in a research note on Monday, August 3rd. Jefferies Financial Group downgraded Cigna Group from a “buy” rating to a “hold” rating and cut their price target for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. UBS Group boosted their price objective on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Wells Fargo & Company upped their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Finally, Cantor Fitzgerald increased their target price on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research report on Friday, May 1st. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

Insider Activity at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is owned by corporate insiders.

Cigna Group Stock Performance

Shares of CI opened at $276.19 on Monday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The stock’s 50-day simple moving average is $284.20 and its 200 day simple moving average is $281.45. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market capitalization of $72.98 billion, a price-to-earnings ratio of 11.43, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the previous year, the firm earned $7.20 EPS. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts forecast that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s payout ratio is currently 25.82%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.